Technology | July 31, 2012

Siemens’ Magnetom Spectra 3.0T MRI System Receives FDA Clearance

Cost-optimized system with Tim 4G and Dot technologies facilitates access to premium 3T imaging

July 31, 2012 — Siemens Healthcare announced that the Magnetom Spectra 3.0T magnetic resonance imaging (MRI) system has received clearance from the U.S. Food and Drug Administration (FDA). The latest addition to Siemens’ portfolio of MRI solutions, the Magnetom Spectra system offers premium imaging at a reduced total cost of ownership when compared to other scanners in the product range. Designed for easy and efficient operation, the cost-optimized Magnetom Spectra system is innovative and competitive, two primary goals of Siemens Healthcare’s Agenda 2013 two-year global initiative.

“Siemens Healthcare is proud to offer the Magnetom Spectra MRI system, which opens the door to 3.0T imaging technology for a wider range of healthcare facilities,” said Ioannis Panagiotelis, Ph.D., vice president of MR, Siemens Healthcare. “The Magnetom Spectra delivers crisp, high-resolution images that provide the key to a new level of usability and diagnostic confidence for physicians.”

The Magnetom Spectra system employs Tim (Total imaging matrix) 4G technology, Siemens’ latest coil generation. This modern array structure allows for high spatial and temporal resolution; previously, images of similar quality could only be produced by 3.0T systems that require a higher investment.

The system also consumes less energy than other 3.0T scanners. The magnet-cooling helium is contained in a closed loop, preventing the gas from escaping and reducing the need for costly refills. In addition, various system components help technologists simplify the MRI examination process. For example, the cableless direct-connect coils allow for simple and quick setup, with up to 120 coil elements capable of being combined in a flexible manner. For this reason, even scans with large anatomical coverage up to whole-body scans (205 cm, or 80.71 inches) can be performed in one examination without patient or coil repositioning.

The Magnetom Spectra system can be used for a broad spectrum of applications, from diagnosing damaged ankle cartilage to conducting dynamic abdominal examinations and performing functional brain imaging. To reduce exam complexity, the system is equipped with Siemens' MRI workflow solution Dot (Day optimizing throughput), which enables easy, fast selection of the best scan strategy based on the patient's condition and the clinical indication. Users benefit from step-by-step guidance throughout the examination, receiving decision-making assistance at critical junctures to support consistent, reproducible scanning across patients.

For more information:

Related Content

Siemens Healthineers Launches New Partners for Digital Ecosystem at HIMSS 2018
News | PACS Accessories | March 12, 2018
At the 2018 Healthcare Information and Management Systems Society (HIMSS) Annual Conference and Exhibition, March 5-9...
Alternative Technique Can Improve Brain Imaging for Restless Children
News | Pediatric Imaging | March 08, 2018
March 8, 2018 – Children often find it difficult to remain still for...
The yellow in the anterolateral entorhinal cortex of the young brain indicates significant activity, something that is absent in the older brain.

This figure shows two different brains that are aligned to a common template space for comparison. The yellow in the anterolateral entorhinal cortex of the young brain indicates significant activity, something that is absent in the older brain. CREDIT: Zachariah Reagh

News | Nuclear Imaging | March 08, 2018
As we get older, it's not uncommon to experience "senior moments," in which we forget where we parked our car or call...
Imaging Plays Key Role in Evaluating Injuries at Olympics
News | Orthopedic Imaging | February 28, 2018
The Olympic Games give elite athletes a chance at athletic triumph, but also carry a risk of injury. When injuries...
FDA Clears Siemens Healthineers' GOKnee3D MRI Application
Technology | Magnetic Resonance Imaging (MRI) | February 19, 2018
The U.S. Food and Drug Administration (FDA) has cleared GOKnee3D, a magnetic resonance imaging (MRI) application from...
A brain MRI. Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns.
Feature | Magnetic Resonance Imaging (MRI) | February 16, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Arterys Receives First FDA Clearance for Oncology Imaging Suite With Deep Learning
Technology | Artificial Intelligence | February 15, 2018
Arterys Inc. announced its fifth 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Arterys...
AHRA and Canon Medical Systems Announce 2017 Putting Patients First Grant Winners
News | Patient Engagement | February 14, 2018
The Association for Medical Imaging Management (AHRA) and Canon Medical Systems recently announced the tenth annual...
Videos | Pediatric Imaging | February 14, 2018
ITN Associate Editor Jeff Zagoudis demonstrates several mobile apps designed to help pediatric patients learn what an
Vantage Galan 3T XGO Edition MRI system was cleared by the FDA.
Technology | Magnetic Resonance Imaging (MRI) | February 12, 2018
February 12, 2018 — Physicians now have access to more neuro and cardiac...
Overlay Init